Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists create 'malaria resistant' mosquitos
Mosquito larvae
By using a gene editing tool called CRISPR, scientists were able to prevent malaria transmission being passed down to 99.5 per cent of offspring.
Findings offer hope for future elimination of the disease
 
US scientists say they have managed to create a genetically modified mosquito that can block malaria infection, preventing its ability to transmit the disease to humans.

While further work is needed, the discovery could one day help to eradicate a disease that kills nearly a million people every year.

Scientists from the University of California (UC) inserted DNA into the germ line of Anopheles stephensi mosquitos - a leading malaria vector in Asia.

This prevented malaria transmission being passed on to 99.5 per cent of the insects' progeny, according to results published in the journal PNAS.

The UC team used a gene editing tool called CRISPR, which allows access to the cell nucleus to snip DNA for replacing mutated genes or inserting new ones.

"This is a significant first step," said Anthony James, a distinguished professor from UC's Irvine campus. "We know the gene works. The mosquitoes we created are not the final brand, but we know this technology allows us to efficiently create large populations."

Malaria is one of the world's leading health concerns, affecting 300-500 million people every year. Over 40 per cent of the world's population live in areas where there is a risk of contracting the disease.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.